Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98


Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.

Page DB, Bear H, Prabhakaran S, Gatti-Mays ME, Thomas A, Cobain E, McArthur H, Balko JM, Gameiro SR, Nanda R, Gulley JL, Kalinsky K, White J, Litton J, Chmura SJ, Polley MY, Vincent B, Cescon DW, Disis ML, Sparano JA, Mittendorf EA, Adams S.

NPJ Breast Cancer. 2019 Oct 8;5:34. doi: 10.1038/s41523-019-0130-x. eCollection 2019. Review.


Tumor-reprogrammed resident T cells resist radiation to control tumors.

Arina A, Beckett M, Fernandez C, Zheng W, Pitroda S, Chmura SJ, Luke JJ, Forde M, Hou Y, Burnette B, Mauceri H, Lowy I, Sims T, Khodarev N, Fu YX, Weichselbaum RR.

Nat Commun. 2019 Sep 2;10(1):3959. doi: 10.1038/s41467-019-11906-2.


The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond.

Onderdonk BE, Chmura SJ.

Front Oncol. 2019 Aug 2;9:706. doi: 10.3389/fonc.2019.00706. eCollection 2019. Review.


Integration of radiotherapy and immunotherapy for treatment of oligometastases.

Pitroda SP, Chmura SJ, Weichselbaum RR.

Lancet Oncol. 2019 Aug;20(8):e434-e442. doi: 10.1016/S1470-2045(19)30157-3. Epub 2019 Jul 29. Review.


Elevated Radiation Therapy Toxicity in the Setting of Germline PTEN Mutation.

Tatebe K, Chmura SJ, Connell PP.

Pract Radiat Oncol. 2019 Jun 8. pii: S1879-8500(19)30163-8. doi: 10.1016/j.prro.2019.06.001. [Epub ahead of print] No abstract available.


Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab.

Bloom BC, Augustyn A, Pezzi TA, Menon H, Mayo LL, Shah SJ, Schwartz DL, Chmura SJ, Johnson FM, Welsh JW, Chun SG.

Front Oncol. 2019 Apr 5;9:223. doi: 10.3389/fonc.2019.00223. eCollection 2019.


National Radiation Oncology Medical Student Clerkship Trends From 2013 to 2018.

Ni L, Chmura SJ, Golden DW.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):24-26. doi: 10.1016/j.ijrobp.2018.12.039. Epub 2018 Dec 31.


Response to BRAF/MEK Inhibition After Progression With BRAF Inhibition in a Patient With Anaplastic Pleomorphic Xanthoastrocytoma.

Hussain F, Horbinski CM, Chmura SJ, Yamini B, Lukas RV.

Neurologist. 2018 Sep;23(5):163-166. doi: 10.1097/NRL.0000000000000194.


Putting the "BR" in SBRT.

Foster CC, Chmura SJ.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):13-14. doi: 10.1016/j.ijrobp.2018.03.043. Epub 2018 Aug 8. No abstract available.


Structured Radiation Oncology Clerkship Curricula: Evaluating the Effect on Residency Applicant Knowledge of Radiation Oncology.

McKillip RP, Kauffmann G, Chmura SJ, Golden DW.

J Am Coll Radiol. 2018 Sep;15(9):1330-1334. doi: 10.1016/j.jacr.2018.05.019. Epub 2018 Jul 13. No abstract available.


Single-institution report of setup margins of voluntary deep-inspiration breath-hold (DIBH) whole breast radiotherapy implemented with real-time surface imaging.

Xiao A, Crosby J, Malin M, Kang H, Washington M, Hasan Y, Chmura SJ, Al-Hallaq HA.

J Appl Clin Med Phys. 2018 Jul;19(4):205-213. doi: 10.1002/acm2.12368. Epub 2018 Jun 22.


Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?

Patel JD, Chmura SJ.

Cancer. 2018 Jul 15;124(14):2878-2880. doi: 10.1002/cncr.31557. Epub 2018 Jun 15. No abstract available.


Reply to S.C. Formenti et al.

Luke JJ, Chmura SJ.

J Clin Oncol. 2018 Sep 1;36(25):2662-2663. doi: 10.1200/JCO.2018.79.0980. Epub 2018 Jun 5. No abstract available.


The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent.

Jutzy JMS, Lemons JM, Luke JJ, Chmura SJ.

Int J Breast Cancer. 2018 May 16;2018:4786819. doi: 10.1155/2018/4786819. eCollection 2018. Review.


Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.

Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK.

PLoS One. 2018 Apr 12;13(4):e0195149. doi: 10.1371/journal.pone.0195149. eCollection 2018.


Mortality After Stereotactic Radiosurgery for Brain Metastases and Implications for Optimal Utilization: A National Cancer Database Study.

Rydzewski NR, Khan AJ, Strauss JB, Chmura SJ.

Am J Clin Oncol. 2018 Apr 10. doi: 10.1097/COC.0000000000000441. [Epub ahead of print]


American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology.

Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Jackie Wu QR, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St James ST, Ulin K, Yom SS, Yock TI.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):1057-1066. doi: 10.1016/j.ijrobp.2017.12.013. Epub 2017 Dec 15. Review.


Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.

Luke JJ, Lemons JM, Karrison TG, Pitroda SP, Melotek JM, Zha Y, Al-Hallaq HA, Arina A, Khodarev NN, Janisch L, Chang P, Patel JD, Fleming GF, Moroney J, Sharma MR, White JR, Ratain MJ, Gajewski TF, Weichselbaum RR, Chmura SJ.

J Clin Oncol. 2018 Jun 1;36(16):1611-1618. doi: 10.1200/JCO.2017.76.2229. Epub 2018 Feb 13.


Case Report of Bone Marrow-Sparing Proton Therapy Craniospinal Irradiation for Central Nervous System Myelomatosis.

Kauffmann G, Buerki RA, Lukas RV, Gondi V, Chmura SJ.

Cureus. 2017 Nov 28;9(11):e1885. doi: 10.7759/cureus.1885.


Retuning the Radio in Radiobiology.

Chmura SJ, Connell PP, Weichselbaum RR.

J Natl Cancer Inst. 2018 Apr 1;110(4):325-326. doi: 10.1093/jnci/djx234. No abstract available.


Radiotherapy for Oligometastatic Lung Cancer.

Bergsma DP, Salama JK, Singh DP, Chmura SJ, Milano MT.

Front Oncol. 2017 Sep 19;7:210. doi: 10.3389/fonc.2017.00210. eCollection 2017. Review.


Management of glioblastoma in elderly patients.

Young JS, Chmura SJ, Wainwright DA, Yamini B, Peters KB, Lukas RV.

J Neurol Sci. 2017 Sep 15;380:250-255. doi: 10.1016/j.jns.2017.07.048. Epub 2017 Aug 1. Review.


Rhythmic radiotherapy beats down TGF-β.

Chmura SJ, Weichselbaum RR.

Cell Cycle. 2017 Aug 3;16(15):1391. doi: 10.1080/15384101.2017.1337970. Epub 2017 Jul 19. No abstract available.


PMRT: Please Mind Randomized Trials.

Wong AC, Chmura SJ.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):976-977. doi: 10.1016/j.ijrobp.2017.04.019. Epub 2017 Jul 10. No abstract available.


Oligometastasis-Directed Ablative Therapy: A Clinical Trial Question.

Melotek JM, Chmura SJ.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):448. doi: 10.1016/j.ijrobp.2016.10.023. No abstract available.


Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States.

Hasan Y, Waller J, Yao K, Chmura SJ, Huo D.

Breast Cancer Res Treat. 2017 Apr;162(2):317-328. doi: 10.1007/s10549-017-4120-0. Epub 2017 Jan 24.


A feasibility study of 2-mm bolus for postmastectomy radiation therapy.

Das LC, Golden DW, Perevalova E, Wong AC, De Nardo K, Stepaniak C, Joyce DS, McCabe BP, Hasan Y, Chmura SJ, McCall A.

Pract Radiat Oncol. 2017 May - Jun;7(3):161-166. doi: 10.1016/j.prro.2016.10.015. Epub 2016 Oct 24.


Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.

Smith GL, Ganz PA, Bekelman JE, Chmura SJ, Dignam JJ, Efstathiou JA, Jagsi R, Johnstone PA, Steinberg ML, Williams SB, Yu JB, Zietman AL, Weichselbaum RR, Tina Shih YC.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):450-461. doi: 10.1016/j.ijrobp.2016.10.042. Epub 2016 Nov 8.


Interdisciplinary Oncology Education: a National Survey of Trainees and Program Directors in the United States.

Akthar AS, Hellekson CD, Ganai S, Hahn OM, Maggiore RJ, Cohen EE, Posner MC, Chmura SJ, Howard AR, Golden DW.

J Cancer Educ. 2018 Jun;33(3):622-626. doi: 10.1007/s13187-016-1139-6.


Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.

Al-Hallaq HA, Chmura SJ, Salama JK, Lowenstein JR, McNulty S, Galvin JM, Followill DS, Robinson CG, Pisansky TM, Winter KA, White JR, Xiao Y, Matuszak MM.

Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):155-163. doi: 10.1016/j.ijrobp.2016.09.030. Epub 2016 Sep 28.


Educational Impact of a Structured Radiation Oncology Clerkship Curriculum: An Interinstitutional Comparison.

Oskvarek JJ, Brower JV, Mohindra P, Raleigh DR, Chmura SJ, Golden DW.

J Am Coll Radiol. 2017 Jan;14(1):96-102. doi: 10.1016/j.jacr.2016.07.017. Epub 2016 Sep 18.


Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).

Wong AC, Watson SP, Pitroda SP, Son CH, Das LC, Stack ME, Uppal A, Oshima G, Khodarev NN, Salama JK, Weichselbaum RR, Chmura SJ.

Cancer. 2016 Jul 15;122(14):2242-50. doi: 10.1002/cncr.30058. Epub 2016 May 20.


Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?

Drazer MW, Salama JK, Hahn OM, Weichselbaum RR, Chmura SJ.

Expert Rev Anticancer Ther. 2016 Jun;16(6):625-32. doi: 10.1080/14737140.2016.1178577. Epub 2016 May 10. Review.


Taking "the Game" Out of The Match: A Simple Proposal.

Wu AJ, Vapiwala N, Chmura SJ, Das P, Decker RH, Terezakis SA, Zietman AL.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):945-8. doi: 10.1016/j.ijrobp.2015.09.039. Epub 2015 Nov 11. No abstract available.


The evolving role of radiotherapy in treatment of oligometastatic NSCLC.

Bergsma DP, Salama JK, Singh DP, Chmura SJ, Milano MT.

Expert Rev Anticancer Ther. 2015;15(12):1459-71. doi: 10.1586/14737140.2015.1105745. Epub 2015 Nov 4. Review.


A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.

Robins HI, Zhang P, Gilbert MR, Chakravarti A, de Groot JF, Grimm SA, Wang F, Lieberman FS, Krauze A, Trotti AM, Mohile N, Kee AY, Colman H, Cavaliere R, Kesari S, Chmura SJ, Mehta M.

J Neurooncol. 2016 Jan;126(2):309-16. doi: 10.1007/s11060-015-1966-z. Epub 2015 Oct 27.


Surgery or ablative radiotherapy for breast cancer oligometastases.

Salama JK, Chmura SJ.

Am Soc Clin Oncol Educ Book. 2015:e8-15. doi: 10.14694/EdBook_AM.2015.35.e8. Review.


Medical Student Perspectives on a Multi-institutional Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group.

Ye JC, Mohindra P, Spektor A, Krishnan MS, Chmura SJ, Howard AR, Viswanathan AN, MacDonald SM, Thaker NG, Das P, Mancini BR, Higgins SA, Braunstein S, Haas-Kogan D, Bradley KA, Hung AY, Thomas CR Jr, Kharofa J, Wheatley M, Currey A, Parashar B, Du K, Jimenez RB, Golden DW.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):217-9. doi: 10.1016/j.ijrobp.2015.01.043. No abstract available.


Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.

Lewis SL, Porceddu S, Nakamura N, Palma DA, Lo SS, Hoskin P, Moghanaki D, Chmura SJ, Salama JK.

Am J Clin Oncol. 2017 Aug;40(4):418-422. doi: 10.1097/COC.0000000000000169.


Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.

LeMieux MH, Solanki AA, Mahmood U, Chmura SJ, Koshy M.

Cancer Med. 2015 Apr;4(4):513-8. doi: 10.1002/cam4.405. Epub 2015 Jan 26.


The role of surgery and ablative radiotherapy in oligometastatic breast cancer.

Salama JK, Chmura SJ.

Semin Oncol. 2014 Dec;41(6):790-7. doi: 10.1053/j.seminoncol.2014.09.016. Epub 2014 Oct 7. Review.


An image-guided study of setup reproducibility of postmastectomy breast cancer patients treated with inverse-planned intensity modulated radiation therapy.

Feng CH, Gerry E, Chmura SJ, Hasan Y, Al-Hallaq HA.

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):58-64. doi: 10.1016/j.ijrobp.2014.09.007. Epub 2014 Oct 22.


Treatment of brain metastases.

Lukas RV, Gabikian P, Garza M, Chmura SJ.

Oncology. 2014;87(6):321-9. doi: 10.1159/000362389. Epub 2014 Sep 6. Review.


Assessment of interfractional variation of the breast surface following conventional patient positioning for whole-breast radiotherapy.

Padilla L, Kang H, Washington M, Hasan Y, Chmura SJ, Al-Hallaq H.

J Appl Clin Med Phys. 2014 Sep 8;15(5):4921. doi: 10.1120/jacmp.v15i5.4921.


Effect of RTOG breast/chest wall guidelines on dose-volume histogram parameters.

Rudra S, Al-Hallaq HA, Feng C, Chmura SJ, Hasan Y.

J Appl Clin Med Phys. 2014 Mar 6;15(2):4547. doi: 10.1120/jacmp.v15i2.4547.


Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.

Corbin KS, Ranck MC, Hasselle MD, Golden DW, Partouche J, Wu T, Chmura SJ, Weichselbaum RR, Salama JK.

Pract Radiat Oncol. 2013 Oct-Dec;3(4):316-22. doi: 10.1016/j.prro.2012.08.006. Epub 2012 Oct 3.


An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

Tye K, Engelhard HH, Slavin KV, Nicholas MK, Chmura SJ, Kwok Y, Ho DS, Weichselbaum RR, Koshy M.

J Neurooncol. 2014 Apr;117(2):321-7. doi: 10.1007/s11060-014-1391-8. Epub 2014 Feb 7.


A national radiation oncology medical student clerkship survey: didactic curricular components increase confidence in clinical competency.

Jagadeesan VS, Raleigh DR, Koshy M, Howard AR, Chmura SJ, Golden DW.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):51-6. doi: 10.1016/j.ijrobp.2013.11.206.


Radiation oncology medical student clerkship: implementation and evaluation of a bi-institutional pilot curriculum.

Golden DW, Spektor A, Rudra S, Ranck MC, Krishnan MS, Jimenez RB, Viswanathan AN, Koshy M, Howard AR, Chmura SJ.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):45-50. doi: 10.1016/j.ijrobp.2013.10.041.


Hypofractionated radiotherapy does not increase acute toxicity in large-breasted women: results from a prospectively collected series.

Corbin KS, Dorn PL, Jain SK, Al-Hallaq HA, Hasan Y, Chmura SJ.

Am J Clin Oncol. 2014 Aug;37(4):322-6. doi: 10.1097/COC.0b013e31827b45b7.


Supplemental Content

Loading ...
Support Center